Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 6345 | 48.73 |
09:34 ET | 100 | 48.69 |
09:36 ET | 800 | 48.52 |
09:38 ET | 1395 | 48.41 |
09:39 ET | 1500 | 48.59 |
09:41 ET | 300 | 48.52 |
09:43 ET | 600 | 48.35 |
09:45 ET | 2400 | 48.64 |
09:48 ET | 500 | 48.855 |
09:50 ET | 600 | 48.85 |
09:52 ET | 700 | 48.865 |
09:54 ET | 5424 | 48.43 |
09:56 ET | 1576 | 48.73 |
09:57 ET | 3723 | 48.81 |
09:59 ET | 1130 | 48.795 |
10:01 ET | 200 | 48.65 |
10:03 ET | 200 | 48.81 |
10:06 ET | 1600 | 48.34 |
10:08 ET | 700 | 48.13 |
10:10 ET | 2865 | 47.975 |
10:12 ET | 400 | 47.83 |
10:14 ET | 900 | 47.54 |
10:15 ET | 435 | 47.46 |
10:17 ET | 3927 | 47.5 |
10:19 ET | 9100 | 47.33 |
10:21 ET | 2497 | 47.435 |
10:24 ET | 600 | 47.3 |
10:26 ET | 1095 | 47.16 |
10:28 ET | 757 | 47.08 |
10:30 ET | 900 | 47.235 |
10:32 ET | 1000 | 47.23 |
10:33 ET | 100 | 47.235 |
10:35 ET | 772 | 47.265 |
10:37 ET | 1480 | 47.15 |
10:39 ET | 200 | 47.15 |
10:42 ET | 2047 | 46.97 |
10:44 ET | 672 | 46.865 |
10:46 ET | 512 | 46.9 |
10:48 ET | 300 | 46.915 |
10:50 ET | 1606 | 47.07 |
10:51 ET | 1723 | 47.215 |
10:53 ET | 210 | 47.25 |
10:55 ET | 2600 | 47.32 |
10:57 ET | 4797 | 47.31 |
11:00 ET | 800 | 47.34 |
11:02 ET | 2161 | 47.33 |
11:04 ET | 1400 | 47.4 |
11:06 ET | 700 | 47.375 |
11:08 ET | 700 | 47.255 |
11:09 ET | 708 | 47.355 |
11:11 ET | 1700 | 47.39 |
11:13 ET | 800 | 47.38 |
11:15 ET | 602 | 47.38 |
11:18 ET | 3900 | 47.395 |
11:20 ET | 2200 | 47.4875 |
11:22 ET | 6873 | 47.445 |
11:24 ET | 1250 | 47.45 |
11:26 ET | 1800 | 47.38 |
11:27 ET | 840 | 47.5 |
11:29 ET | 300 | 47.47 |
11:31 ET | 100 | 47.45 |
11:33 ET | 700 | 47.575 |
11:36 ET | 1950 | 47.495 |
11:38 ET | 700 | 47.59 |
11:40 ET | 100 | 47.55 |
11:42 ET | 100 | 47.54 |
11:44 ET | 100 | 47.615 |
11:45 ET | 1263 | 47.56 |
11:47 ET | 900 | 47.59 |
11:49 ET | 100 | 47.56 |
11:51 ET | 100 | 47.55 |
11:56 ET | 1400 | 47.51 |
11:58 ET | 200 | 47.54 |
12:00 ET | 100 | 47.52 |
12:02 ET | 800 | 47.565 |
12:03 ET | 3997 | 47.495 |
12:05 ET | 400 | 47.49 |
12:07 ET | 2261 | 47.51 |
12:09 ET | 3151 | 47.51 |
12:12 ET | 4085 | 47.445 |
12:14 ET | 2708 | 47.5 |
12:16 ET | 2098 | 47.575 |
12:20 ET | 100 | 47.64 |
12:21 ET | 1000 | 47.51 |
12:23 ET | 200 | 47.52 |
12:25 ET | 300 | 47.575 |
12:30 ET | 600 | 47.5 |
12:32 ET | 889 | 47.5 |
12:34 ET | 100 | 47.51 |
12:36 ET | 300 | 47.48 |
12:38 ET | 700 | 47.51 |
12:39 ET | 300 | 47.52 |
12:41 ET | 200 | 47.5 |
12:43 ET | 200 | 47.53 |
12:45 ET | 2144 | 47.485 |
12:48 ET | 600 | 47.5 |
12:50 ET | 200 | 47.5 |
12:52 ET | 1100 | 47.52 |
12:56 ET | 1088 | 47.51 |
12:57 ET | 150 | 47.53 |
01:01 ET | 850 | 47.51 |
01:03 ET | 1200 | 47.5 |
01:06 ET | 8321 | 47.43 |
01:08 ET | 1063 | 47.53 |
01:10 ET | 100 | 47.52 |
01:12 ET | 8071 | 47.44 |
01:14 ET | 1950 | 47.575 |
01:15 ET | 300 | 47.58 |
01:17 ET | 1730 | 47.61 |
01:19 ET | 490 | 47.59 |
01:21 ET | 200 | 47.635 |
01:24 ET | 1000 | 47.76 |
01:26 ET | 100 | 47.67 |
01:28 ET | 100 | 47.67 |
01:30 ET | 3623 | 47.625 |
01:32 ET | 1100 | 47.63 |
01:33 ET | 712 | 47.645 |
01:35 ET | 930 | 47.75 |
01:37 ET | 300 | 47.8 |
01:39 ET | 400 | 47.81 |
01:42 ET | 1900 | 47.91 |
01:44 ET | 1317 | 47.96 |
01:46 ET | 500 | 47.95 |
01:48 ET | 703 | 47.99 |
01:50 ET | 1721 | 47.9025 |
01:51 ET | 500 | 47.88 |
01:53 ET | 500 | 47.98 |
01:55 ET | 700 | 47.91 |
01:57 ET | 1172 | 48 |
02:00 ET | 814 | 47.96 |
02:02 ET | 1300 | 47.84 |
02:04 ET | 1012 | 47.95 |
02:06 ET | 600 | 47.9 |
02:08 ET | 300 | 47.86 |
02:09 ET | 200 | 47.78 |
02:11 ET | 600 | 47.59 |
02:13 ET | 700 | 47.585 |
02:15 ET | 200 | 47.54 |
02:18 ET | 100 | 47.63 |
02:22 ET | 200 | 47.54 |
02:24 ET | 958 | 47.52 |
02:26 ET | 100 | 47.51 |
02:27 ET | 836 | 47.5 |
02:31 ET | 400 | 47.49 |
02:33 ET | 1136 | 47.47 |
02:36 ET | 300 | 47.52 |
02:38 ET | 300 | 47.49 |
02:40 ET | 448 | 47.5 |
02:42 ET | 462 | 47.5 |
02:44 ET | 1800 | 47.5 |
02:45 ET | 250 | 47.495 |
02:47 ET | 3404 | 47.5 |
02:49 ET | 200 | 47.495 |
02:51 ET | 6600 | 47.57 |
02:54 ET | 400 | 47.57 |
02:56 ET | 572 | 47.51 |
02:58 ET | 300 | 47.51 |
03:00 ET | 100 | 47.48 |
03:02 ET | 600 | 47.5 |
03:03 ET | 1710 | 47.59 |
03:05 ET | 300 | 47.635 |
03:07 ET | 2554 | 47.57 |
03:09 ET | 938 | 47.59 |
03:12 ET | 413 | 47.645 |
03:14 ET | 100 | 47.645 |
03:16 ET | 636 | 47.58 |
03:18 ET | 100 | 47.54 |
03:20 ET | 100 | 47.57 |
03:21 ET | 2114 | 47.745 |
03:23 ET | 1410 | 47.58 |
03:27 ET | 790 | 47.47 |
03:30 ET | 453 | 47.47 |
03:32 ET | 526 | 47.5 |
03:34 ET | 1331 | 47.52 |
03:36 ET | 1100 | 47.56 |
03:38 ET | 400 | 47.53 |
03:39 ET | 603 | 47.565 |
03:41 ET | 600 | 47.55 |
03:43 ET | 2504 | 47.59 |
03:45 ET | 1603 | 47.56 |
03:48 ET | 804 | 47.55 |
03:50 ET | 1100 | 47.555 |
03:52 ET | 2983 | 47.57 |
03:54 ET | 2835 | 47.62 |
03:56 ET | 2273 | 47.6575 |
03:57 ET | 8844 | 47.705 |
03:59 ET | 96865 | 47.79 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 8.8B | -30.5x | --- |
Ascendis Pharma A/S | 8.5B | -14.8x | --- |
Intra-Cellular Therapies Inc | 7.6B | -83.7x | --- |
Tempus AI Inc | 7.6B | -6.0x | --- |
Revolution Medicines Inc | 7.7B | -12.7x | --- |
Blueprint Medicines Corp | 5.6B | -25.7x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.8B |
---|---|
Revenue (TTM) | $456.0M |
Shares Outstanding | 184.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.10 |
EPS | $-1.57 |
Book Value | $6.88 |
P/E Ratio | -30.5x |
Price/Sales (TTM) | 19.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.